You have 9 free searches left this month | for more free features.

Sunitinib

Showing 26 - 50 of 729

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Rivoceranib Mesylate, Paclitaxel
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023

Renal Cell Carcinoma, Metastatic Trial in Worldwide (Intuvax (INN: ilixadencel), Sunitinib)

Completed
  • Renal Cell Carcinoma, Metastatic
  • Intuvax (INN: ilixadencel)
  • Sunitinib
  • Chicago, Illinois
  • +27 more
Jul 23, 2022

Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)

Active, not recruiting
  • Paraganglioma
  • Pheochromocytoma
  • Sunitinib
  • Calgary, Alberta, Canada
  • +3 more
Nov 29, 2021

Renal Cell Carcinoma Metastatic Trial in Hershey (Abemaciclib, Sunitinib)

Active, not recruiting
  • Renal Cell Carcinoma Metastatic
  • Hershey, Pennsylvania
    Penn State Cancer Institute
Jan 5, 2022

Kidney Tumors, Metastatic Renal Cell Cancer Trial in Besancon (Sunitinib)

Active, not recruiting
  • Kidney Neoplasms
  • Metastatic Renal Cell Cancer
  • Sunitinib
  • Besancon, Franche-ComtĂ©, France
    CHU Besancon
Nov 17, 2021

CR With Sunitinib Treatment In mRCC Patients

Completed
  • Complete Remission in Renal Cell Carcinoma
  • sunitinib
  • Marseille, Cedex 5, France
  • +13 more
Feb 14, 2022

Renal Cell Carcinoma Trial (Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • Sunitinib
  • (no location specified)
Sep 11, 2023

Non GIST Sarcomas Trial in France (sunitinib)

Completed
  • Non GIST Sarcomas
  • sunitinib
  • Bordeaux, France
  • +5 more
Jan 3, 2022

Liver Cancer Trial in France (sunitinib malate, Placebo, transarterial chemoembolization)

Completed
  • Liver Cancer
  • sunitinib malate
  • +2 more
  • Amiens, France
  • +30 more
Mar 17, 2022

Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Tokyo, Japan
    A site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022

Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab

Recruiting
  • Soft Tissue Sarcoma
  • Bone Sarcoma
  • Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
  • +7 more
  • Bologna, Italy
  • +12 more
Nov 10, 2021

Gastrointestinal Stromal Tumors Trial in Changsha (Apatinib Mesylate, Sunitinib, Imatinib dosage, Dasatinib, Reveratinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Apatinib Mesylate
  • Sunitinib, Imatinib dosage, Dasatinib, Reveratinib
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
Mar 1, 2023

Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)

Completed
  • Diabetic Macular Edema
  • Retina Vein Occlusion
  • Phoenix, Arizona
  • +5 more
Nov 18, 2021

Small Cell Lung Cancer Trial in United States (irinotecan, Carboplatin, sunitinib)

Completed
  • Small Cell Lung Cancer
  • Fort Myers, Florida
  • +9 more
Nov 19, 2021

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Lung Neuroendocrine Tumor, GEP Neuroendocrine Tumor Trial in Naples (Cabozantinib and Temozolomide)

Recruiting
  • Lung Neuroendocrine Neoplasm
  • GEP Neuroendocrine Tumor
  • Cabozantinib and Temozolomide
  • Naples, Campania, Italy
    National Cancer Institute of Naples
Oct 12, 2021

Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)

Recruiting
  • Type B3 Thymoma
  • Thymic Carcinoma
  • Sunitinib
  • Milan, Italy
    National Cancer Institute
Jun 8, 2021

Metastatic Renal Cell Carcinoma Trial in Paris (Nephrectomy, Sunitinib alone)

Completed
  • Metastatic Renal Cell Carcinoma
  • Nephrectomy
  • Sunitinib alone
  • Paris, France
    Hopital Necker
Apr 13, 2021

Carcinoma, Renal Cell Trial in China, Korea, Republic of, Taiwan (Pazopanib, Sunitinib)

Completed
  • Carcinoma, Renal Cell
  • Guangzhou, Guangdong, China
  • +20 more
Dec 6, 2021

Avapritinib in Chinese Gastrointestinal Stromal Tumor in Real

Recruiting
  • Gastrointestinal Stromal Tumors
  • Avapritinib
  • Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 14, 2022

Kidney Cancer Trial in Boston, Houston, Salt Lake City (Everolimus, Sunitinib)

Terminated
  • Kidney Cancer
  • Boston, Massachusetts
  • +3 more
Apr 26, 2021

Kidney Cancer Trial in New Brunswick (therapeutic allogeneic lymphocytes, sunitinib malate)

Terminated
  • Kidney Cancer
  • therapeutic allogeneic lymphocytes
  • sunitinib malate
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 23, 2021

Glioblastoma Multiforme, Glioblastoma, Adult, Glioblastoma Trial in Amsterdam, Groningen, Nijmegen (Sunitinib, Lomustine)

Recruiting
  • Glioblastoma Multiforme
  • +4 more
  • Amsterdam, Netherlands
  • +2 more
Apr 14, 2021

Advanced Rare Tumours Trial in Canada (Sunitinib, Temsirolimus)

Active, not recruiting
  • Advanced Rare Tumours
  • Calgary, Alberta, Canada
  • +16 more
Mar 17, 2022

Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)

Active, not recruiting
  • Carcinoma
  • +7 more
  • La Jolla, California
  • +58 more
Jan 13, 2023